Evidence map›Paper›PMID 41577745›Full record

ArticleScientific reports2026

ABCC6 pathogenic variants are associated with hemorrhagic phenotypes in Japanese patients with severe cerebral small vessel disease.

Sho Kitahara, Shoichiro Ando, Masahiro Uemura, Yuya Hatano, Hiroaki Nozaki, Daisuke Hirozawa, Emi Nomura, Kohei Okubo, Asami Munekane, Takumi Tashiro and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sho KitaharaDepartment of Neurology, Brain Research Institute, Niigata University, 1-757, Asahimachi-Dori, Chuoku, Niigata, 951-8585, Japan.
Shoichiro AndoDepartment of Neurology, Brain Research Institute, Niigata University, 1-757, Asahimachi-Dori, Chuoku, Niigata, 951-8585, Japan.
Masahiro UemuraDepartment of Neurology, Brain Research Institute, Niigata University, 1-757, Asahimachi-Dori, Chuoku, Niigata, 951-8585, Japan.
Yuya HatanoDepartment of Neurology, Brain Research Institute, Niigata University, 1-757, Asahimachi-Dori, Chuoku, Niigata, 951-8585, Japan.
Hiroaki NozakiDepartment of Medical Technology, Graduate School of Health Sciences, Niigata University, Niigata, Japan.
Daisuke HirozawaDepartment of Neurology, Osaka University, Osaka, Japan.
Emi NomuraDepartment of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Kohei OkuboDivision of Neurology, Kawasaki Medical School, Okayama, Japan.
Asami MunekaneDivision of Neurology, Kawasaki Medical School, Okayama, Japan.
Takumi TashiroDepartment of Neurology, JCHO Kyushu Hospital, Fukuoka, Japan.
Kanako AsaiDepartment of Neurology, Osaka General Medical Centre, Osaka, Japan.
Minako YamaokaDepartment of Neurology, Nara Medical University, Nara, Japan.
Tomone TanedaDepartment of Neurology, Nagaoka Red Cross Hospital, Niigata, Japan.
Yutaka HonmaDepartment of Neurology, Showa General Hospital, Tokyo, Japan.
Hajime KondoDepartment of Neurology, Anjo Kosei Hospital, Aichi, Japan.
Ryo ItabashiDepartment of Stroke Neurology, Kohnan Hospital, Miyagi, Japan.
Akira IwanagaDepartment of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hiroyuki MurotaDepartment of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hitoshi AizawaDepartment of Neurology, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Tomohiko IshiharaDepartment of Neurology, Brain Research Institute, Niigata University, 1-757, Asahimachi-Dori, Chuoku, Niigata, 951-8585, Japan.
Osamu OnoderaDepartment of Neurology, Brain Research Institute, Niigata University, 1-757, Asahimachi-Dori, Chuoku, Niigata, 951-8585, Japan. onodera@bri.niigata-u.ac.jp.

Funding

AMED 19ek0109236h0003Japanese Ministry of Health, Labour and Welfare 21FC0201MEXT 26117006Takeda Science Foundation 19H01043
6 · The paper itself

Abstract

ABCC6 pathogenic variants affect ischemic and hemorrhagic lesions in multiple organs and represent the third most common cause of hereditary cerebral small vessel diseases (CSVD) in Japan, yet their CSVD phenotypes remains unclear. We conducted a multicenter, cross-sectional study of 158 consecutive Japanese adults with severe CSVD. Genetic analysis was performed, and clinical and brain MRI findings were compared among ABCC6-related CSVD, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and genetically undetermined CSVD. Univariate and multivariate analyses assessed the association between ABCC6 pathogenic variants and hemorrhagic stroke, adjusting for age and hypertension. Nine patients (5.7%) carried pathogenic heterozygous ABCC6 variants. Hemorrhagic stroke was more frequent in ABCC6-related CSVD than in CADASIL (55.6% vs 13.6%, P = 0.039) and undetermined CSVD (55.6% vs 10.3%, P = 0.010). Multivariate analysis confirmed an independent association (odds ratio 8.4, 95% CI 2.0-38.4, P = 0.004). On MRI, ABCC6-related CSVD showed fewer anterior temporal lesions but more multiple microbleeds than CADASIL. The direction of these findings remained consistent when biallelic cases were included. These findings indicate a distinct, hemorrhage-predominant CSVD phenotype associated with ABCC6 in Japanese patients, support a contributory role of ABCC6, and warrant validation in larger, multi‑ethnic cohorts.

Indexed as

ATP-Binding Cassette, Sub-Family C ProteinsCerebral HemorrhageCerebral Small Vessel DiseasesAdultAgedCross-Sectional StudiesEast Asian PeopleFemaleHumansJapanMagnetic Resonance ImagingMaleMiddle AgedPhenotypeABCC6 protein, humanATP-Binding Cassette, Sub-Family C ProteinsCADASILCerebral hemorrhageGeneticsLeukoaraiosisPseudoxanthoma elasticum

Identifiers

PMID41577745
PMCPMC12852805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.